Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Open accessThe DOI matches its Crossref record; 273 of the 276 references it cites were found in a registry or an index.
Abstract
We describe a recently recognized disease entity, limbic-predominant age-related TDP-43 encephalopathy (LATE). LATE neuropathological change (LATE-NC) is defined by a stereotypical TDP-43 proteinopathy in older adults, with or without coexisting hippocampal sclerosis pathology. LATE-NC is a common TDP-43 proteinopathy, associated with an amnestic dementia syndrome that mimicked Alzheimer's-type dementia in retrospective autopsy studies. LATE is distinguished from frontotemporal lobar degeneration with TDP-43 pathology based on its epidemiology (LATE generally affects older subjects), and relatively restricted neuroanatomical distribution of TDP-43 proteinopathy. In community-based autopsy cohorts, ∼25% of brains had sufficient burden of LATE-NC to be associated with discernible cognitive impairment. Many subjects with LATE-NC have comorbid brain pathologies, often including amyloid-β plaques and tauopathy. Given that the 'oldest-old' are at greatest risk for LATE-NC, and subjects of advanced age constitute a rapidly growing demographic group in many countries, LATE has an expanding but under-recognized impact on public health. For these reasons, a working group was convened to develop diagnostic criteria for LATE, aiming both to stimulate research and to promote awareness of this pathway to dementia. We report consensus-based recommendations including guidelines for diagnosis and staging of LATE-NC. For routine autopsy workup of LATE-NC, an anatomically-based preliminary staging scheme is proposed with TDP-43 immunohistochemistry on tissue from three brain areas, reflecting a hierarchical pattern of brain involvement: amygdala, hippocampus, and middle frontal gyrus. LATE-NC appears to affect the medial temporal lobe structures preferentially, but other areas also are impacted. Neuroimaging studies demonstrated that subjects with LATE-NC also had atrophy in the medial temporal lobes, frontal cortex, and other brain regions. Genetic studies have thus far indicated five genes with risk alleles for LATE-NC: GRN, TMEM106B, ABCC9, KCNMB2, and APOE. The discovery of these genetic risk variants indicate that LATE shares pathogenetic mechanisms with both frontotemporal lobar degeneration and Alzheimer's disease, but also suggests disease-specific underlying mechanisms. Large gaps remain in our understanding of LATE. For advances in prevention, diagnosis, and treatment, there is an urgent need for research focused on LATE, including in vitro and animal models. An obstacle to clinical progress is lack of diagnostic tools, such as biofluid or neuroimaging biomarkers, for ante-mortem detection of LATE. Development of a disease biomarker would augment observational studies seeking to further define the risk factors, natural history, and clinical features of LATE, as well as eventual subject recruitment for targeted therapies in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Statistical analyses on data related to LATE from the Rush University community-based autopsy cohort depicting the results of pathway analyses. Data were analysed from research volunteers (total n = 1309) in two clinical‐pathological studies of ageing from Rush University as described previously (Power et al., 2018). In this sample, the mean age of death was 89.7 years [standard deviation (SD) 6.5 years, range 65–108 years]. These analyses incorporated age, density of amyloid-β neuritic amyloid plaques (to factor in ADNC), TDP-43 proteinopathy, hippocampal sclerosis pathology, and the endpoint of Alzheimer’s-type clinical dementia. The components of the pathway analyses most strongly associated with LATE-NC are shown in red. The numbers are path coefficients with standard error in parentheses (shown in purple). These numbers help to quantify the effects of individual pathways. For instance, the data are compatible with there being two pathways from TDP-43 proteinopathy to dementia, one direct pathway (TDP-43 proteinopathy→dementia) and the other indirect pathway that includes hippocampal sclerosis pathology (TDP-43 proteinopathy→hippocampal sclerosis→dementia): in the statistical model, the TDP-43 proteinopathy is independently associated with both hippocampal sclerosis pathology and clinical dementia status. Further, the data indicate that a subset of TDP-43 proteinopathy is ‘downstream’ of ADNC-type neuritic amyloid plaque pathology. In a practical sense, this means that brains with more neuritic amyloid plaques are more likely to have TDP-43 proteinopathy, with all other known factors being the same. Aβ = amyloid-β.](https://figures.cochat.ai/paper-figures/9bc83b3adf7f42d5a250b59d9652e7a1/limbic-predominant-age-related-tdp-43-encephalopathy-late-consensus-working-figure-2.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A consensus group, for example, has described hippocampal sclerosis associated with TDP-43 proteinopathy, as limbic-predominant age-related TDP-43 encephalopathy (LATE) dementia, usually found in people older than 80 years, progressing more slowly than Alzheimer's disease, detectable at post-mortem, often mimicking or comorbid with Alzheimer's disease.3”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“50–60% of Alzheimer’s-type dementia (dementia defined clinically as Alzheimer’s disease) is estimated to be attributable to these copathologies.40,42–45”
From Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group (2021) · cites this paper as [45]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“LATE is a recently described entity which affects older people and presents with an amnestic picture resembling Alzheimer's disease 178 .”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [178]
The cited source says what the claim attributes to it.
In the citing paper
“Limbic-predominant age-related TDP43 encephalopathy (LATE), defined approximately 3 years ago, is a condition in which typical TDP43 protein inclusions are present with or without coexisting hippocampal sclerosis.29”
From Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations (2022) · cites this paper as [29]
The cited source says what the claim attributes to it.
In the citing paper
“The predominant neuropathological change in LATE is TDP-43 proteinopathy, which is associated with a clinical presentation of amnestic dementia that can mimic Alzheimer's dementia.”
From Concordance of Clinical Alzheimer Diagnosis and Neuropathological Features at Autopsy (2020) · cites this paper as [20]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Self-citationAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Self-citationBlessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117 · cited 1×
“LATE-NC is mostly seen in the oldest-old, whereas in early clinical-pathological correlation studies of dementia (Roth et al., 1966; Blessed et al., 1968), the research subjects had died in their early 70s.”
BackgroundAssociation of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature · doi:10.1038/nature19323 · Cited by 3,059 · cited 1×
“This stratification will enable enrichment for subjects on the ADNC continuum (Sevigny et al., 2016) while excluding subjects likely to have high risk for LATE-NC (Botha et al., 2018).”
BackgroundMontine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894
Self-citationStages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194 · cited 1×
“seen at autopsy with every year of advanced old age (Braak et al., 2011; Nelson et al., 2011a, 2013; Brenowitz et al., 2014; Neltner et al., 2016).”
BackgroundPorta, M. (2026) · doi:10.1093/acref/9780197663639.001.0001 · Cited by 2,175
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., et al. (2006) · Nature · doi:10.1038/nature05016 · Cited by 2,058
Self-citation
Research works printed but not linked: 3
- Kuslansky G, Verghese J, Dickson D, Katz M, Busche H, Lipton RB Hippocampal sclerosis: cognitive consequences and contribution to dementia. Neurology 2004; 62: A128– 9.
- Porta M. Dictionary of Epidemiology. 6th edn. New York: Oxford University Press; 2014.
- Thom M, Sisodiya S Epilepsy. In: Love S, Perry A, Ironside JW, Budka H, editors. Greenfield’s Neuropathology. New York: CRC Press; 2015 p. 683– 739.
Cited by
Items 501–600 of 1,004
Watanabe, H., Hikida, S., Ikeda, M., & Mori, E. (2022) · Brain Communications · doi:10.1093/braincomms/fcac015 · Cited by 23
Wu, X., Peng, C., Nelson, P. T., & Cheng, Q. S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256648 · Cited by 22
Self-citationStudy of neuropathological changes and dementia in 100 centenarians in The 90+ Study
Neuville, R. S., Biswas, R., Ho, C., Bukhari, S. A., Sajjadi, S. A., Paganini‐Hill, A., Montine, T. J., Corrada, M. M., & Kawas, C. H. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12981 · Cited by 22
Self-citationShenoy, J., Lends, A., Berbon, M., Abdul-Shukkoor, M. B., Mammeri, N. E., Bertoni, M., Saad, A., Morvan, E., Grélard, A., Lecomte, S., et al. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1148302 · Cited by 22
van Amerongen, S., Kamps, S., Kaijser, K. K. M., Pijnenburg, Y. A. L., Scheltens, P., Teunissen, C. E., Barkhof, F., Ossenkoppele, R., Rozemüller, A. J. M., Stern, R. A., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01572-3 · Cited by 22
LATE-NC risk alleles (in TMEM106B, GRN, and ABCC9 genes) among persons with African ancestry
Katsumata, Y., Fardo, D. W., Shade, L. M. P., Bowen, J. D., Crane, P. K., Jarvik, G. P., Keene, C. D., Larson, E. B., McCormick, W. C., McCurry, S. M., et al. (2023) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlad059 · Cited by 22
Self-citationIdentifying and Diagnosing TDP-43 Neurodegenerative Diseases in Psychiatry
Ducharme, S., Pijnenburg, Y. A. L., Rohrer, J. D., Huey, E. D., Finger, E. C., & Tatton, N. A. (2023) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2023.08.017 · Cited by 22
Denning, A. E., Ittyerah, R., Levorse, L. M., Sadeghpour, N., Athalye, C., Chung, E. P., Ravikumar, S., Dong, M., Duong, M. T., Li, Y., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02789-9 · Cited by 22
The Alzheimer's Disease Neuroimaging Initiative Neuropathology Core: An update
Perrin, R. J., Franklin, E. E., Bernhardt, H., Burns, A., Schwetye, K. E., Cairns, N. J., Baxter, M., Weiner, M. W., Morris, J. C., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14253 · Cited by 22
Stathmin-2 enhances motor axon regeneration after injury independent of its binding to tubulin
Beccari, M. S., Arnold-García, O., Baughn, M. W., Artates, J. W., McAlonis‐Downes, M., Lim, J., Leyva-Cázares, D. F., Rubio-Lara, H. I., Ramirez-Rodriguez, A., Bernal-Buenrostro, C. N., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2502294122 · Cited by 22
Advances in pathophysiology and neuroimaging: Implications for sleep and dementia
Ward, S. A., & Pase, M. P. (2019) · Respirology · doi:10.1111/resp.13728 · Cited by 24
Smeltzer, S., Quadri, Z., Miller, A., Zamudio, F., Hunter, J., Stewart, N. J., Saji, S., Lee, D. C., Chaput, D., & Selenica, M. B. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165939 · Cited by 23
Teylan, M., Mock, C., Gauthreaux, K. M., Culhane, J. E., Jicha, G. A., Chen, Y., Chan, K. C. G., Kukull, W. A., Nelson, P. T., & Katsumata, Y. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab098 · Cited by 22
Self-citationYu, L., Huo, Z., Yang, J., Palma‐Gudiel, H., Boyle, P. A., Schneider, J. A., Bennett, D. A., & Zhao, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.765259 · Cited by 23
Self-citationSaiyasit, N., Butlig, E.-A. R., Chaney, S. D., Traylor, M. K., Hawley, N. A., Randall, R. B., Bobinger, H. V., Frizell, C. A., Trimm, F., Crook, E. D., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.915405 · Cited by 22
Qian, J., Zhang, Y., Betensky, R. A., Hyman, B. T., & Serrano‐Pozo, A. (2023) · Neurology Genetics · doi:10.1212/nxg.0000000000200055 · Cited by 23
Therapeutic Potential of Neu1 in Alzheimer’s Disease Via the Immune System
Khan, A., Das, S. K., & Sergi, C. M. (2021) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317521996147 · Cited by 22
Tam, S., Wear, D., Morrone, C. D., & Yu, W. H. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16108 · Cited by 21
Regulation of physiological and pathological condensates by molecular chaperones
Akaree, N., Secco, V., Levy‐Adam, F., Younis, A., Carra, S., & Shalgi, R. (2025) · FEBS Journal · doi:10.1111/febs.17390 · Cited by 21
Quantification of perforant path fibers for early detection of Alzheimer's disease
Uchida, Y., Hou, Z., Gómez-Isaza, L., Luongo, M., Troncoso, J. C., Miller, M. I., Mori, S., & Oishi, K. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70142 · Cited by 21
Shaw, L. M. J., Korecka, M., Figurski, M., Toledo, J. B., Irwin, D. J., Kang, J., & Trojanowski, J. Q. (2019) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2019.029587 · Cited by 21
Self-citationPlano, L. M. D., Carnazza, S., Franco, D., Rizzo, M. G., Conoci, S., Petralia, S., Nicoletti, A. S. Q., Zappia, M., Campolo, M., Esposito, E., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00549 · Cited by 21
Neuropsychiatric Aspects of Frontotemporal Dementia
Younes, K., & Miller, B. L. (2020) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2020.02.005 · Cited by 14
Olson, N. L., & Albensi, B. C. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200214 · Cited by 21
Genetic Insights into Alzheimer's Disease
Latimer, C. S., Lucot, K. L., Keene, C. D., Cholerton, B., & Montine, T. J. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032551 · Cited by 21
Self-citationDiagnosis and Management of Cognitive Concerns in the Oldest-Old
Borders, C. B., & Sajjadi, S. A. (2021) · Current Treatment Options in Neurology · doi:10.1007/s11940-021-00665-5 · Cited by 22
A multifaceted role of progranulin in regulating amyloid-beta dynamics and responses
Du, H., Wong, M. Y., Zhang, T., Santos, M. N., Hsu, C., Zhang, J., Yu, H., Luo, W., & Hu, F. (2021) · Life Science Alliance · doi:10.26508/lsa.202000874 · Cited by 21
Neuropathologic Correlates of Human Cortical Proteins in Alzheimer Disease and Related Dementias
Yu, L., Boyle, P. A., Wingo, A. P., Yang, J., Wang, T., Buchman, A. S., Wingo, T. S., Seyfried, N. T., Levey, A. I., Jager, P. L. D., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000013252 · Cited by 21
Self-citationProtracted course progressive supranuclear palsy
Couto, B., Martínez-Valbuena, I., Lee, S., Alfradique‐Dunham, I., Perrin, R. J., Perlmutter, J. S., Cruchaga, C., Kim, A., Visanji, N. P., Sato, C., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15346 · Cited by 21
Sajjadi, S. A., Bukhari, S. A., Scambray, K. A., Yan, R., Kawas, C. H., Montine, T. J., & Corrada, M. M. (2022) · Neurology · doi:10.1212/wnl.0000000000201345 · Cited by 21
Self-citationGibbons, L. E., Power, M. C., Walker, R. L., Kumar, R. G., Murphy, A., Latimer, C. S., Nolan, A., Melief, E. J., Beller, A., Bogdani, M., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221224 · Cited by 21
Self-citationŠprung, J., Warner, D. O., Knopman, D. S., Petersen, R. C., Mielke, M. M., Jack, C. R., Lowe, V. J., Martin, D. P., Hanson, A. C., Schroeder, D. R., et al. (2020) · British Journal of Anaesthesia · doi:10.1016/j.bja.2020.01.015 · Cited by 21
Self-citationCerebrovascular markers of WMH and infarcts in ADNI: A historical perspective and future directions
Maillard, P., Fletcher, E. M., Carmichael, O. T., Schwarz, C. G., Seiler, S., DeCarli, C. S., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14358 · Cited by 20
Vulnerability to memory decline in aging revealed by a mega-analysis of structural brain change
Dídac Vidal-piñeiro, A., Sørensen, Ø., Strømstad, M., Amlien, I. K., Baaré, W. F. C., Bartrés‐Faz, D., Brandmaier, A. M., Cattaneo, G., Düzel, S., Ghisletta, P., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66354-y · Cited by 20
Self-citationInsulin-like growth factor 5 associates with human Aß plaques and promotes cognitive impairment
Rauskolb, S., Andreska, T., Fries, S., von Collenberg, C. R., Blum, R., Monoranu, C., Villmann, C., & Sendtner, M. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01352-5 · Cited by 20
Symptoms and conventional treatments of Alzheimer's disease
Chorawala, M. R., Shah, A. C., Pandya, A. J., Kothari, N. R., & Prajapati, B. G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00009-1 · Cited by 21
Jellinger, K. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072942 · Cited by 20
Amygdalar and hippocampal volume loss in limbic-predominant age-related TDP-43 encephalopathy
Wesseling, A. J., Calandri, I. L., Bouwman, M. M. A., Reijner, N., Deshayes, N. A. C., Barkhof, F., Ossenkoppele, R., van de Berg, W. D. J., Rozemüller, A. J. M., Pijnenburg, Y. A. L., et al. (2025) · Brain · doi:10.1093/brain/awaf201 · Cited by 20
Llibre‐Guerra, J. J., Lee, S. E., Suemoto, C. K., Ehrenberg, A. J., Kovács, G. G., Karydas, A., Staffaroni, A. M., Resende, E. D. P. F., Kim, E., Hwang, J., et al. (2021) · Brain Pathology · doi:10.1111/bpa.12924 · Cited by 20
Self-citationBachstetter, A. D., Garrett, F. G., Jicha, G. A., & Nelson, P. T. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01152-3 · Cited by 20
Self-citationConformational dynamics in the disordered region of human CPEB3 linked to memory consolidation
de Mingo, D. R., Pantoja‐Uceda, D., Hervás, R., Carrión‐Vázquez, M., & Laurents, D. V. (2022) · BMC Biology · doi:10.1186/s12915-022-01310-6 · Cited by 20
Oveisgharan, S., Yu, L., Wang, T., Schneider, J. A., Bennett, D. A., & Buchman, A. S. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac128 · Cited by 20
Self-citationRifai, O. M., Longden, J., O’Shaughnessy, J., Sewell, M. D. E., Pate, J. A., McDade, K., Daniels, M. J. D., Abrahams, S., Chandran, S., McColl, B. W., et al. (2022) · The Journal of Pathology · doi:10.1002/path.6008 · Cited by 20
McAleese, K. E., Walker, L., Erskine, D., Johnson, M. A., Koss, D. J., Thomas, A. J., & Attems, J. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12664 · Cited by 20
Self-citationExtracellular vesicles in TDP-43 proteinopathies: pathogenesis and biomarker potential
Dellar, E. R., Nikel, L., Fowler, S. L., Vahsen, B. F., Dafinca, R., Feneberg, E., Talbot, K., Turner, M. R., & Thompson, A. G. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00859-4 · Cited by 19
Gawor, K., Verrept, S., Arekatla, G., Wouters, D., Ronisz, A., Hecht, M., Laureyssen, C., Donck, H. V., Lahaije, B., Ospitalieri, S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70483 · Cited by 21
Midkine attenuates amyloid-β fibril assembly and plaque formation
Zaman, M., Yang, S., Huang, Y., Yarbro, J. M., Hao, Y., Wang, Z., Liu, D., Harper, K. E., Soliman, H., Hemphill, A., et al. (2025) · Nature Structural & Molecular Biology · doi:10.1038/s41594-025-01657-8 · Cited by 19
Metformin and Dementia Risk: A Systematic Review with Respect to Time Related Biases
Dai, J., Ports, K. D., Corrada, M. M., Odegaard, A., O’Connell, J., & Jiang, L. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220002 · Cited by 19
Samudra, N. P., Ranasinghe, K. G., Kirsch, H. E., Rankin, K. P., & Miller, B. L. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220983 · Cited by 20
Jarholm, J. A., Bjørnerud, A., Dalaker, T. O., Akhavi, M. S., Kirsebom, B., Pålhaugen, L., Nordengen, K., Grøntvedt, G. R., Nakling, A. E., Kalheim, L. F., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221274 · Cited by 19
A Mechanism Underpinning the Bioenergetic Metabolism‐Regulating Function of Gold Nanocatalysts
Wang, Z., Henriques, A., Rouvière, L., Callizot, N., Tan, L., Hotchkin, M. T., Rossignol, R., Mortenson, M. G., Dorfman, A. R., Ho, K. S., et al. (2023) · Small · doi:10.1002/smll.202304082 · Cited by 19
Targeting Progranulin as an Immuno-Neurology Therapeutic Approach
Boylan, M. A., Pincetic, A., Romano, G. J., Tatton, N. A., Kenkare-Mitra, S., & Rosenthal, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115946 · Cited by 19
Pecher, H., Storch, M., Beyer, F., Witte, A. V., Baasner, C.-F., Schönknecht, P. O. D., & Weise, C. M. (2024) · NeuroImage Clinical · doi:10.1016/j.nicl.2024.103687 · Cited by 19
Large-scale RNA-Seq mining reveals ciclopirox olamine induces TDP-43 cryptic exons
Sinha, I. R., Sandal, P. S., Spence, H., Burns, G. D., Mallika, A. P., Abbasinejad, F., Irwin, K. E., Cruz, A. L., Wang, V., Marx, S. R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62004-5 · Cited by 19
Verheijen, B. M., Lussier, C., Müller-Hübers, C., Garruto, R. M., Oyanagi, K., Braun, R. J., & van Leeuwen, F. W. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz110 · Cited by 19
Robinson, A., Roncaroli, F., Davidson, Y. S., Minshull, J., Heal, C., Montaldi, D., Payton, A., Horan, M. A., Pendleton, N., & Mann, D. M. A. (2020) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5470 · Cited by 19
Bermejo‐Pareja, F., Ciudad-Cabañas, M. J., Velasco, S. L., Tapias-Merino, E., Hernández‐Gallego, J., Hernández‐Cabria, M., Collado-Yurrita, L., & López‐Arrieta, J. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa045 · Cited by 19
Lee, H. J., Lee, E.-C., Seo, S., Ko, K., Kang, J. M., Kim, W., Seo, H., Lee, S.-Y., Lee, Y., Park, K. H., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.615467 · Cited by 19
Buciuc, M., Tosakulwong, N., Machulda, M. M., Whitwell, J. L., Weigand, S. D., Murray, M. E., Reichard, R. R., Parisi, J. E., Dickson, D. W., Boeve, B. F., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201166 · Cited by 19
Self-citationTreyer, V., Meyer, R., Buchmann, A., Crameri, G. A. G., Studer, S. T., Saake, A., Gruber, E., Unschuld, P. G., Nitsch, R. M., Höck, C., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247225 · Cited by 19
Lagarde, J., Olivieri, P., Tonietto, M., Gervais, P., Comtat, C., Caillé, F., Bottlaender, M., & Sarazin, M. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01628-9 · Cited by 19
Devoy, A., Price, G., Giorgio, F. D., Bunton-Stasyshyn, R. K. A., Thompson, D., Gasco, S., Allan, A. J., Codner, G. F., Nair, R., Tibbit, C., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103463 · Cited by 19
Kothapalli, S. V. V. N., Benzinger, T. L. S., Aschenbrenner, A. J., Perrin, R. J., Hildebolt, C. F., Goyal, M. S., Fagan, A. M., Raichle, M. E., Morris, J. C., & Yablonskiy, D. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210503 · Cited by 19
Reyes‐Leiva, D., Dols‐Icardo, O., Sirisi, S., Cortés‐Vicente, E., Turón‐Sans, J., de Luna, N., Blesa, R., Belbin, O., Montal, V., Alcolea, D. A., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.750543 · Cited by 19
Quintas-Neves, M., Teylan, M., Morais‐Ribeiro, R., Almeida, F., Mock, C., Kukull, W. A., Crary, J. F., & Oliveira, T. G. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.04.013 · Cited by 19
Self-citationWalker, J. M., Gonzales, M. M., Goette, W. F., Farrell, K. W., White, C. L., Crary, J. F., & Richardson, T. E. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230022 · Cited by 19
Association between WWOX/MAF variants and dementia-related neuropathologic endophenotypes
Dugan, A. J., Nelson, P. T., Katsumata, Y., Shade, L. M. P., Teylan, M., Boehme, K. L., Mukherjee, S., Kauwe, J. S. K., Hohman, T. J., Schneider, J. A., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.10.011 · Cited by 18
Self-citationCerebrospinal Fluid Biomarker Profile in TDP-43-Related Genetic Frontotemporal Dementia
Kapaki, E. N., Boufidou, F., Bourbouli, M., Pyrgelis, E.-S., Constantinides, V. C., Anastassopoulou, C. G., & Paraskevas, G. P. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12101747 · Cited by 18
Arco, J. E., Ortíz, A., Castillo-Barnés, D., Górriz, J. M., & Ramírez, J. (2023) · Applied Soft Computing · doi:10.1016/j.asoc.2023.109991 · Cited by 18
The unique neuropathological vulnerability of the human brain to aging
Ferrer, I. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101916 · Cited by 18
Martínez‐González, L., Cuevas, E. P., Tosat‐Bitrián, C., Nozal, V., Gil, C., Palomo, V., Martín‐Requero, Á., & Martínez, A. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1243277 · Cited by 18
Tracing TMEM106B fibril deposition in aging and Parkinson’s disease with dementia brains
Zhao, W., Fan, Y., Zhao, Q., Fan, Z., Zhao, J., Yu, W., Li, W., Li, D., Liu, C., & Wang, J. (2024) · Life Medicine · doi:10.1093/lifemedi/lnae011 · Cited by 18
Villareal, J. A. B., Bathe, T., Hery, G. P., Phillips, J. L., Tsering, W., & Prokop, S. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03196-3 · Cited by 20
Yushkevich, P. A., Ittyerah, R., Li, Y., Denning, A. E., Sadeghpour, N., Lim, S., McGrew, E., Xie, L., de Florès, R., Brown, C. A., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14161 · Cited by 19
CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study
Plantone, D., Pardini, M., Manco, C., Righi, D., Alì, P. A., Arnaldi, D., Pelagotti, V., Massa, F., d’Alessandro, M., Bargagli, E., et al. (2025) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864251314773 · Cited by 18
Banks, S. J., Qiu, Y., Fan, C. C., Dale, A. M., Zou, J., Askew, B., Feldman, H., & Initiative, A. D. N. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12071 · Cited by 18
Williams, B. D., Pendleton, N., & Chandola, T. (2021) · Aging Neuropsychology and Cognition · doi:10.1080/13825585.2021.1889958 · Cited by 18
Hippocampal sclerosis of aging at post‐mortem is evident on MRI more than a decade prior
Ortega‐Cruz, D., Iglesias, J. E., Rábano, A., & Strange, B. A. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13352 · Cited by 18
Chan, C. K., Soldan, A., Pettigrew, C. A., Wang, J., Albert, M., & Rosenberg, P. B. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12106 · Cited by 18
Nelson, P. T., Dickson, D. W., Trojanowski, J. Q., Jack, C. R., Boyle, P. A., Arfanakis, K., Rademakers, R., Alafuzoff, I. I., Attems, J., Brayne, C., et al. (2019) · Brain · doi:10.1093/brain/awz226 · Cited by 18
Self-citationGal, J., Katsumata, Y., Zhu, H., Srinivasan, S., Chen, J., Johnson, L. A., Wang, W.-X., Golden, L. R., Wilcock, D. M., Jicha, G. A., et al. (2022) · The American Journal of Pathology · doi:10.1016/j.ajpath.2021.11.013 · Cited by 17
Self-citationα-Synuclein seed amplification assay positivity beyond synucleinopathies
Martínez-Valbuena, I., Fullam, S., O’Dowd, S., Tartaglia, M. C., & Kovács, G. G. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105925 · Cited by 17
When sleep fails, brain clearance suffers: the role of glymphatic impairment in clinical neurology
la Herrán-Arita, A. K. D. (2025) · Acta Neurologica Belgica · doi:10.1007/s13760-025-02959-w · Cited by 17
Sakurai, K., Kaneda, D., Morimoto, S., Uchida, Y., Inui, S., Kimura, Y., Kan, H., Kato, T., Ito, K., & Hashizume, Y. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230068 · Cited by 17
Distinct involvement of the cranial and spinal nerves in progressive supranuclear palsy
Tanaka, H., Martínez-Valbuena, I., Forrest, S. L., Couto, B., Reyes, N. G. D., Morales‐Rivero, A., Lee, S., Li, J., Karakani, A. M., Tang‐Wai, D. F., et al. (2023) · Brain · doi:10.1093/brain/awad381 · Cited by 17
Yusuf, I. O., Parsi, S., Ostrow, L. W., Brown, R. H., Thompson, P. R., & Xu, Z. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106414 · Cited by 17
Cheng, F., Chapman, T. R., Zhang, S., Morsch, M., Chung, R. S., Lee, A., & Rayner, S. L. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102246 · Cited by 17
Brain aging and Alzheimer’s disease, a perspective from non-human primates
Ferrer, I. (2024) · Aging · doi:10.18632/aging.206143 · Cited by 17
Common neuropathologic change drivers of hippocampal sclerosis of ageing
Woodworth, D. C., Lou, J., Yong, W. H., Head, E., Corrada, M. M., Nelson, P. T., & Sajjadi, S. A. (2025) · Brain · doi:10.1093/brain/awaf158 · Cited by 17
Self-citationMurray, M. E., Smith, C., Menon, V., Keene, C. D., Lein, E. S., Hawrylycz, M., Aguzzi, A., Benedetti, B. L., Brose, K., Caetano-Anollés, K., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.06.014 · Cited by 17
Self-citationMIND Diet and Hippocampal Sclerosis Among Community-Based Older Adults
Agarwal, P., Agrawal, S., Wagner, M., Cherian, L. J., Aggarwal, N. T., James, B. D., Holland, T. M., Bennett, D. A., Barnes, L. L., Leurgans, S. E., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.26089 · Cited by 17
Self-citationShwab, E. K., Pathak, G. A., Harvey, J., Belloy, M. E., Fischer, C. E., Lutz, M. W., Scholz, S. W., Cook, N., Reid, D. M., Chen, J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70549 · Cited by 17
A unified model of dementias and age‐related neurodegeneration
Fossel, M. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12012 · Cited by 17
Genetic risk for Alzheimer’s disease influences neuropathology via multiple biological pathways
Hannon, E. J., Shireby, G. L., Brookes, K. J., Attems, J., Sims, R., Cairns, N. J., Love, S., Thomas, A. J., Morgan, K., Francis, P. T., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa167 · Cited by 17
Self-citationOh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau
McCollum, L., Das, S. R., Xie, L., de Florès, R., Wang, J., Xie, S. X., Wisse, L. E. M., Yushkevich, P. A., & Wolk, D. A. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102717 · Cited by 17
Richter, N., David, L.-S., Grothe, M. J., Teipel, S. J., Dietlein, M., Tittgemeyer, M., Neumaier, B., Fink, G. R., Onur, O. A., & Kukolja, J. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-210261 · Cited by 17
TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration
Buciuc, M., Martin, P. R., Tosakulwong, N., Murray, M. E., Petrucelli, L., Senjem, M. L., Spychalla, A. J., Knopman, D. S., Boeve, B. F., Petersen, R. C., et al. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.102954 · Cited by 17
Self-citationTau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey
da Costa, P. J., Hamdane, M., Buée, L., & Martin, F. (2022) · Biomedicines · doi:10.3390/biomedicines10020241 · Cited by 17
Old age amyotrophic lateral sclerosis and limbic TDP‐43 pathology
Murakami, A., Koga, S., Sekiya, H., Oskarsson, B., Boylan, K., Petrucelli, L., Josephs, K. A., & Dickson, D. W. (2022) · Brain Pathology · doi:10.1111/bpa.13100 · Cited by 17
Self-citationCracco, L., Doud, E. H., Hallinan, G. I., Garringer, H. J., Jacobsen, M. H., Richardson, R. M., Buratti, E., Vidal, R., Ghetti, B. F., & Newell, K. L. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12836 · Cited by 17
Metadata
- Authors
- Nelson, P. T., Dickson, D. W., Trojanowski, J. Q., Jack, C. R., Boyle, P. A., Arfanakis, K., Rademakers, R., Alafuzoff, I., Attems, J., Brayne, C., Coyle-Gilchrist, I. T. S., Chui, H. C., Fardo, D. W., Flanagan, M. E., Halliday, G., Hokkanen, S. R. K., Hunter, S., Jicha, G. A., Katsumata, Y., Kawas, C. H., Keene, C. D., Kovacs, G. G., Kukull, W. A., Levey, A. I., Makkinejad, N., Montine, T. J., Murayama, S., Murray, M. E., Nag, S., Rissman, R. A., Seeley, W. W., Sperling, R. A., White III, C. L., Yu, L., & Schneider, J. A.
- Affiliations
- University of Kentucky (US)
- Mayo Clinic in Florida (US)
- University of Pennsylvania (US)
- Mayo Clinic (US)
- Rush University Medical Center (US)
- Uppsala University (SE)
- Newcastle University (GB)
- University of Cambridge (GB)
- University of Southern California (US)
- University of Minnesota (US)
- The University of Sydney (AU)
- University of California, Irvine (US)
- University of Washington (US)
- Institute of Neurology Medical University of Vienna, Vienna, Austria
- Emory University (US)
- Illinois Institute of Technology (US)
- Stanford University (US)
- Tokyo Metropolitan Institute of Gerontology (JP)
- University of California San Diego (US)
- University of California, San Francisco (US)
- Harvard University (US)
- University of Texas Southwestern Medical Center, Dallas, TX, USA
- Corresponding author
- Nelson, Peter T
- ORCID
- Nelson, Peter T
- Dickson, Dennis W
- Trojanowski, John Q
- Jack, Clifford R
- Boyle, Patricia A
- Arfanakis, Konstantinos
- Rademakers, Rosa
- Alafuzoff, Irina
- Attems, Johannes
- Brayne, Carol
- Coyle-Gilchrist, Ian T S
- Chui, Helena C
- Fardo, David W
- Flanagan, Margaret E
- Halliday, Glenda
- Hokkanen, Suvi R K
- Hunter, Sally
- Jicha, Gregory A
- Katsumata, Yuriko
- Kawas, Claudia H
- Keene, C Dirk
- Kukull, Walter A
- Levey, Allan I
- Makkinejad, Nazanin
- Montine, Thomas J
- Murayama, Shigeo
- Murray, Melissa E
- Nag, Sukriti
- Rissman, Robert A
- Seeley, William W
- Sperling, Reisa A
- Yu, Lei
- Schneider, Julie A
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-04-30
- Volume
- 142
- Issue
- 6
- Pages
- 1503-1527
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC6536849
- OpenAlex
- W2943828894
- Cited by
- 1,547
- References
- 276
- Citations by year
- 2026: 206 · 2025: 240 · 2024: 211 · 2023: 214 · 2022: 213 · 2021: 193 · 2020: 198 · 2019: 66
- FWCI
- 113.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion, cc-by-nc)
- Apollo (University of Cambridge) (submittedVersion, cc-by-nc)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc)
- Apollo
- Funders
- NIA
- NACC
- NIH (U01 AG016976)
- National Health and Medical Research Council
- NHMRC (1132524, 1095127, 1037746)
- Senior Principal Research Fellowship (1079679)
- National Institutes of Health (P01 AG003949, R01 AG037491, P50 AG016574, R01 AG054449, P30 AG028303, P30 AG012300, P30 AG049638, P30 AG010124, P30 AG010161, P50 AG047366, P50 AG025688, P50 AG005131, R37 AG011378, R01 AG041851, R01 AG042210, R01 AG017917, R01 AG034374, UF1 AG053983, UF1 AG057707)
- NIHR (534906, NF-SI-0616–10090)
- National Institute for Health Research
- NHS
- Department of Health and Social Care
- Addenbrooke’s Charitable Trust
- Paul G. Allen Family Foundation and Alzheimer’s Research
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- limbic-predominant age-related TDP-43 encephalopathy, TDP-43 proteinopathy, hippocampal sclerosis, diagnostic criteria, neuropathological staging, amygdala, medial temporal lobe atrophy, genetic risk variants, gene regulatory networks, TMEM106B, ABCC9, apolipoprotein E, Alzheimer's disease, frontotemporal lobar degeneration
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Brain, Brain Diseases, Female, Humans, Male, Middle Aged, Retrospective Studies, Frontotemporal Lobar Degeneration, TDP-43 Proteinopathies, Frontotemporal Dementia, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.